Direxion Daily TSLA Bull 1.5X Shares

Mast Therapeutics, Inc.

GraniteShares 1.5x Long NVDA Daily ETF

GraniteShares 1.5x Long META Daily ETF

GraniteShares 1.5x Long Coinbase Daily ETF

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

AXS 2X Innovation ETF

Volatility Shares Trust 2x Ether ETF

Direxion Daily Technology Bull 3X ETF

VS TR 2x Long VIX Futures ETF

ProShares Ultra VIX Short-Term Futures

MicroSectors Gold Miners 3X Leveraged ETN

Bank Of Montreal

iShares Nasdaq Biotechnology

Direxion Technology Bear 3X Shares

iPath S&P 500 VIX ST Futures ETN

ProShares UltraPro Short QQQ

Direxion Daily Gold Miners Bull 3X ETF

BigBear.ai Inc. Common Stock

Spire Global Inc. Class A Common Stock

Pony AI Inc. American Depositary Shares

Charter Communications Inc. Class A Common Stock New

Rezolve AI Limited Ordinary Shares

Tesla Inc. Common Stock

Comfort Systems USA Inc. Common Stock

PENN Entertainment Inc. Common Stock

SolarEdge Technologies Inc. Common Stock

RE/MAX Holdings Inc. Class A Common Stock

Adecoagro S.A. Common Shares

Carter's Inc. Common Stock

T-Mobile US Inc. Common Stock

Old Dominion Freight Line Inc. Common Stock

Intel Corporation Common Stock

Annexon Inc. Common Stock

Eastern Bankshares Inc. Common Stock

Skechers U.S.A. Inc. Common Stock

Apollo Global Management Inc. (New) Common Stock

Click here to get full coverage on Why Aditxt Inc. (ADTX) Went Down On Thursday? - Yahoo Finance

Why Aditxt Inc. (ADTX) Went Down On Thursday?  Yahoo Finance

Why Aditxt Inc. (ADTX) Went Down On Thursday? - Yahoo Finance

Click here to get full coverage on Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-250 Reverse Stock Split Effective at the Open of Trading on March 17, 2025 - Business Wire

Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-250 Reverse Stock Split Effective at the Open of Trading on March 17, 2025  Business Wire

Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-250 Reverse Stock Split Effective at the Open of Trading on March 17, 2025 - Business Wire

Click here to get full coverage on ADITXT Earnings Preview: Recent $ADTX Insider Trading, Hedge Fund Activity, and More - Nasdaq

ADITXT Earnings Preview: Recent $ADTX Insider Trading, Hedge Fund Activity, and More  Nasdaq

ADITXT Earnings Preview: Recent $ADTX Insider Trading, Hedge Fund Activity, and More - Nasdaq

Click here to get full coverage on Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 - PR Newswire

Evofem Biosciences Announces Financial Results for the Third Quarter of 2024  PR Newswire

Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 - PR Newswire

Click here to get full coverage on Aditxt, Inc. (NASDAQ: ADTX) Regains Compliance with Nasdaq Listing Requirements - Business Wire

Aditxt, Inc. (NASDAQ: ADTX) Regains Compliance with Nasdaq Listing Requirements  Business Wire

Aditxt, Inc. (NASDAQ: ADTX) Regains Compliance with Nasdaq Listing Requirements - Business Wire

Click here to get full coverage on Aditxt, Inc. (NASDAQ: ADTX) Regains Compliance with Nasdaq Listi - GuruFocus

Aditxt, Inc. (NASDAQ: ADTX) Regains Compliance with Nasdaq Listi  GuruFocus

Aditxt, Inc. (NASDAQ: ADTX) Regains Compliance with Nasdaq Listi - GuruFocus

Click here to get full coverage on Why Aditxt (ADTX) Stock Is Skyrocketing - Benzinga

Why Aditxt (ADTX) Stock Is Skyrocketing  Benzinga

Why Aditxt (ADTX) Stock Is Skyrocketing - Benzinga

Click here to get full coverage on ADTX stock plunges to 52-week low, touches $0.07 - Investing.com

ADTX stock plunges to 52-week low, touches $0.07  Investing.com

ADTX stock plunges to 52-week low, touches $0.07 - Investing.com

Click here to get full coverage on Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on October 2, 2024 - Stock Titan

Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on October 2, 2024  Stock Titan

Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on October 2, 2024 - Stock Titan

Click here to get full coverage on Aditxt Inc. (ADTX) reports earnings - qz.com

Aditxt Inc. (ADTX) reports earnings  qz.com

Aditxt Inc. (ADTX) reports earnings - qz.com

Click here to get full coverage on Pre-market Movers: RGC, SYRS, ADTX, ATXI... - RTTNews

Pre-market Movers: RGC, SYRS, ADTX, ATXI...  RTTNews

Pre-market Movers: RGC, SYRS, ADTX, ATXI... - RTTNews

Click here to get full coverage on ADTX stock plunges to 52-week low, touches $0.18 - Investing.com

ADTX stock plunges to 52-week low, touches $0.18  Investing.com

ADTX stock plunges to 52-week low, touches $0.18 - Investing.com

Click here to get full coverage on Evofem Posts Record 4th Year Growth: Revenue Up 6% as Operating Costs Plunge 27% - Stock Titan

Evofem Posts Record 4th Year Growth: Revenue Up 6% as Operating Costs Plunge 27%  Stock Titan

Evofem Posts Record 4th Year Growth: Revenue Up 6% as Operating Costs Plunge 27% - Stock Titan

Click here to get full coverage on ADTX stock plunges to 52-week low, touches $0.42 - Investing.com

ADTX stock plunges to 52-week low, touches $0.42  Investing.com

ADTX stock plunges to 52-week low, touches $0.42 - Investing.com

Click here to get full coverage on Aditxt to Host Fireside Chat on Friday, February 21st at 11:30 AM Eastern Time - Business Wire

Aditxt to Host Fireside Chat on Friday, February 21st at 11:30 AM Eastern Time  Business Wire

Aditxt to Host Fireside Chat on Friday, February 21st at 11:30 AM Eastern Time - Business Wire

Click here to get full coverage on ADTX stock plunges to 52-week low of $0.32 amid market challenges - Investing.com

ADTX stock plunges to 52-week low of $0.32 amid market challenges  Investing.com

ADTX stock plunges to 52-week low of $0.32 amid market challenges - Investing.com

Click here to get full coverage on Appili President and CEO, Don Cilla Will Join Aditxt Co-founder and CEO, Amro Albanna, at the Aditxt Weekly Update on April 4, 2025 - Business Wire

Appili President and CEO, Don Cilla Will Join Aditxt Co-founder and CEO, Amro Albanna, at the Aditxt Weekly Update on April 4, 2025  Business Wire

Appili President and CEO, Don Cilla Will Join Aditxt Co-founder and CEO, Amro Albanna, at the Aditxt Weekly Update on April 4, 2025 - Business Wire

Click here to get full coverage on Aditxt Provides Business Status Overview and Announces Launch of Aditxt Weekly Update Starting Friday, March 21, 2025 - Business Wire

Aditxt Provides Business Status Overview and Announces Launch of Aditxt Weekly Update Starting Friday, March 21, 2025  Business Wire

Aditxt Provides Business Status Overview and Announces Launch of Aditxt Weekly Update Starting Friday, March 21, 2025 - Business Wire

Click here to get full coverage on Aditxt regains Nasdaq compliance, updates on operations - Investing.com

Aditxt regains Nasdaq compliance, updates on operations  Investing.com

Aditxt regains Nasdaq compliance, updates on operations - Investing.com

Click here to get full coverage on Evofem Biosciences Announces Financial Results for the Second Quarter of 2024 - PR Newswire

Evofem Biosciences Announces Financial Results for the Second Quarter of 2024  PR Newswire

Evofem Biosciences Announces Financial Results for the Second Quarter of 2024 - PR Newswire

Click here to get full coverage on ADTX stock plunges to 52-week low, touches $0.04 - Investing.com

ADTX stock plunges to 52-week low, touches $0.04  Investing.com

ADTX stock plunges to 52-week low, touches $0.04 - Investing.com

Click here to get full coverage on Aditxt Weekly Update to Highlight Recent Events, Including Regaining Compliance with Nasdaq Listing Requirements - Business Wire

Aditxt Weekly Update to Highlight Recent Events, Including Regaining Compliance with Nasdaq Listing Requirements  Business Wire

Aditxt Weekly Update to Highlight Recent Events, Including Regaining Compliance with Nasdaq Listing Requirements - Business Wire

Click here to get full coverage on ADTX stock touches 52-week low at $1.07 amid steep annual decline - Investing.com

ADTX stock touches 52-week low at $1.07 amid steep annual decline  Investing.com

ADTX stock touches 52-week low at $1.07 amid steep annual decline - Investing.com

Click here to get full coverage on Evofem Secures Key Merger Support as Aditxt Completes $5M Investment Commitment - Stock Titan

Evofem Secures Key Merger Support as Aditxt Completes $5M Investment Commitment  Stock Titan

Evofem Secures Key Merger Support as Aditxt Completes $5M Investment Commitment - Stock Titan

Click here to get full coverage on Aditxt (ADTX) Study Reinforces ADI-100's Promise in Autoimmune T - GuruFocus

Aditxt (ADTX) Study Reinforces ADI-100's Promise in Autoimmune T  GuruFocus

Aditxt (ADTX) Study Reinforces ADI-100's Promise in Autoimmune T - GuruFocus

Click here to get full coverage on 10 Stocks Fall Behind Amid Market Optimism - Insider Monkey

10 Stocks Fall Behind Amid Market Optimism  Insider Monkey

10 Stocks Fall Behind Amid Market Optimism - Insider Monkey

Click here to get full coverage on 12 Health Care Stocks Moving In Monday's Intraday Session - Aditxt (NASDAQ:ADTX), Alumis (NASDAQ:ALMS) - Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session - Aditxt (NASDAQ:ADTX), Alumis (NASDAQ:ALMS)  Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session - Aditxt (NASDAQ:ADTX), Alumis (NASDAQ:ALMS) - Benzinga

Click here to get full coverage on Aditxt approves reverse stock split, adjourns special meeting - Investing.com

Aditxt approves reverse stock split, adjourns special meeting  Investing.com

Aditxt approves reverse stock split, adjourns special meeting - Investing.com

Click here to get full coverage on Dr. Charles Howe of the Mayo Clinic's Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt's Subsidiary Adimune™ - Quantisnow

Dr. Charles Howe of the Mayo Clinic's Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt's Subsidiary Adimune™  Quantisnow

Dr. Charles Howe of the Mayo Clinic's Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt's Subsidiary Adimune™ - Quantisnow

Click here to get full coverage on Aditxt Announces $1.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - Business Wire

Aditxt Announces $1.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules  Business Wire

Aditxt Announces $1.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - Business Wire

Click here to get full coverage on Rhythm Pharmaceuticals (RYTM): Surge in Interest Following Positive Trial Results | ADTX Stock News - GuruFocus

Rhythm Pharmaceuticals (RYTM): Surge in Interest Following Positive Trial Results | ADTX Stock News  GuruFocus

Rhythm Pharmaceuticals (RYTM): Surge in Interest Following Positive Trial Results | ADTX Stock News - GuruFocus

Click here to get full coverage on Aditxt extends merger agreement end date to January 2025 - Investing.com

Aditxt extends merger agreement end date to January 2025  Investing.com

Aditxt extends merger agreement end date to January 2025 - Investing.com

Click here to get full coverage on Aditxt’s Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission - Business Wire

Aditxt’s Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission  Business Wire

Aditxt’s Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission - Business Wire

Click here to get full coverage on Is the Market Bullish or Bearish on Aditxt? - Aditxt (NASDAQ:ADTX) - Benzinga

Is the Market Bullish or Bearish on Aditxt? - Aditxt (NASDAQ:ADTX)  Benzinga

Is the Market Bullish or Bearish on Aditxt? - Aditxt (NASDAQ:ADTX) - Benzinga

Click here to get full coverage on Aditxt Weekly Update to Highlight Recent Events, Including Regaining Compliance with Nasdaq Listing Requirements | ADTX Stock News - GuruFocus

Aditxt Weekly Update to Highlight Recent Events, Including Regaining Compliance with Nasdaq Listing Requirements | ADTX Stock News  GuruFocus

Aditxt Weekly Update to Highlight Recent Events, Including Regaining Compliance with Nasdaq Listing Requirements | ADTX Stock News - GuruFocus

Click here to get full coverage on Aditxt faces Nasdaq delisting over share price rule - Investing.com

Aditxt faces Nasdaq delisting over share price rule  Investing.com

Aditxt faces Nasdaq delisting over share price rule - Investing.com

Click here to get full coverage on Aditxt shares fall on 1-for-250 reverse stock split - MSN

Aditxt shares fall on 1-for-250 reverse stock split  MSN

Aditxt shares fall on 1-for-250 reverse stock split - MSN

Click here to get full coverage on Aditxt invests $1.5 million in Evofem amid merger talks By Investing.com - Investing.com

Aditxt invests $1.5 million in Evofem amid merger talks By Investing.com  Investing.com

Aditxt invests $1.5 million in Evofem amid merger talks By Investing.com - Investing.com

Click here to get full coverage on Aditxt announces 1-for-250 reverse stock split - Investing.com

Aditxt announces 1-for-250 reverse stock split  Investing.com

Aditxt announces 1-for-250 reverse stock split - Investing.com

Click here to get full coverage on 12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session  Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Click here to get full coverage on S&P 500 Down 1%; Sarepta Therapeutics Shares Plunge - Aditxt (NASDAQ:ADTX), FinVolution Group (NYSE:FINV) - Benzinga

S&P 500 Down 1%; Sarepta Therapeutics Shares Plunge - Aditxt (NASDAQ:ADTX), FinVolution Group (NYSE:FINV)  Benzinga

S&P 500 Down 1%; Sarepta Therapeutics Shares Plunge - Aditxt (NASDAQ:ADTX), FinVolution Group (NYSE:FINV) - Benzinga

Click here to get full coverage on Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem - Business Wire

Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem  Business Wire

Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem - Business Wire

Click here to get full coverage on Aditxt, Inc. Discusses Pearsanta’s Planned IPO and Innovations - TipRanks

Aditxt, Inc. Discusses Pearsanta’s Planned IPO and Innovations  TipRanks

Aditxt, Inc. Discusses Pearsanta’s Planned IPO and Innovations - TipRanks

Click here to get full coverage on Aditxt, Inc. Plans IPO for Pearsanta in 2025 - TipRanks

Aditxt, Inc. Plans IPO for Pearsanta in 2025  TipRanks

Aditxt, Inc. Plans IPO for Pearsanta in 2025 - TipRanks

Click here to get full coverage on Aditxt, Inc. extends merger agreement with Evofem Biosciences - Investing.com

Aditxt, Inc. extends merger agreement with Evofem Biosciences  Investing.com

Aditxt, Inc. extends merger agreement with Evofem Biosciences - Investing.com

Click here to get full coverage on Aditxt explores IPO for subsidiary Pearsanta in 2025 - Investing.com

Aditxt explores IPO for subsidiary Pearsanta in 2025  Investing.com

Aditxt explores IPO for subsidiary Pearsanta in 2025 - Investing.com

Click here to get full coverage on Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga

Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket  Benzinga

Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga

Click here to get full coverage on Aditxt’s Subsidiary Pearsanta Gets IRB Approval - MSN

Aditxt’s Subsidiary Pearsanta Gets IRB Approval  MSN

Aditxt’s Subsidiary Pearsanta Gets IRB Approval - MSN

Click here to get full coverage on Aditxt secures $256K through senior note sales - Investing.com Australia

Aditxt secures $256K through senior note sales  Investing.com Australia

Aditxt secures $256K through senior note sales - Investing.com Australia

Click here to get full coverage on Crude Oil Falls 1%; Dollar General Posts Upbeat Sales - Benzinga

Crude Oil Falls 1%; Dollar General Posts Upbeat Sales  Benzinga

Crude Oil Falls 1%; Dollar General Posts Upbeat Sales - Benzinga

Click here to get full coverage on Aditxt Delivers Shareholder Update and 2024 Year-End Plan - Business Wire

Aditxt Delivers Shareholder Update and 2024 Year-End Plan  Business Wire

Aditxt Delivers Shareholder Update and 2024 Year-End Plan - Business Wire

Click here to get full coverage on Aditxt, Inc. Highlights Strategic Partnership with Evofem - TipRanks

Aditxt, Inc. Highlights Strategic Partnership with Evofem  TipRanks

Aditxt, Inc. Highlights Strategic Partnership with Evofem - TipRanks

Click here to get full coverage on Aditxt to Host a Virtual Fireside Chat with Aditxt CEO Amro Albanna and Evofem CEO Saundra Pelletier, Moderated by MD & Media Personality Dr. Drew Pinsky, on October 28, 2024, at 11:30 AM Eastern Time - Business Wire

Aditxt to Host a Virtual Fireside Chat with Aditxt CEO Amro Albanna and Evofem CEO Saundra Pelletier, Moderated by MD & Media Personality Dr. Drew Pinsky, on October 28, 2024, at 11:30 AM Eastern Time  Business Wire

Aditxt to Host a Virtual Fireside Chat with Aditxt CEO Amro Albanna and Evofem CEO Saundra Pelletier, Moderated by MD & Media Personality Dr. Drew Pinsky, on October 28, 2024, at 11:30 AM Eastern Time - Business Wire

Click here to get full coverage on 12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session  Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Click here to get full coverage on Aditxt suspends equity financing amid acquisition strategy - Investing.com

Aditxt suspends equity financing amid acquisition strategy  Investing.com

Aditxt Inc. (ADTX)

Price Chart

Key Statistics

Technicals

About ADTX

Latest News

Why Aditxt Inc. (ADTX) Went Down On Thursday? - Yahoo Finance

Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-250 Reverse Stock Split Effective at the Open of Trading on March 17, 2025 - Business Wire

ADITXT Earnings Preview: Recent $ADTX Insider Trading, Hedge Fund Activity, and More - Nasdaq

Advanced Charts

Top Gainers

Top Losers